Differences in Placental Pathology Between COVID-19-Induced Preeclampsia-Like Syndrome and True Preeclampsia.
AIM Women with COVID-19 may develop preeclampsia-like syndrome, which shares some of the clinical features of preeclampsia (PE) but lacks its characteristic angiogenic imbalance (elevated soluble fms-like tyrosine kinase-1-to-placental growth factor ratio (sFlt-1/PlGF ratio)), suggesting the absence of placental involv...